Report Detail
Global Oncology/Cancer Drugs Market Professional Survey Report 2019
- RnM3766833 |
- 20 September, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.
The global Oncology/Cancer Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Oncology/Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncology/Cancer Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Oncology/Cancer Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Oncology/Cancer Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche
HENGRUI
AstraZeneca
QILU
Sanofi
HANSOH
LUYE
Novartis
GuiZhou YiBai
Lunan
Eli Lilly and Company
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Antimetabolite
Alkaloid drugs
Hormone
Targeted drug
Platinum-based drugs
Other
Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
Table of Contents
Executive Summary
1 Industry Overview of Oncology/Cancer Drugs
- 1.1 Definition of Oncology/Cancer Drugs
- 1.2 Oncology/Cancer Drugs Segment by Type
- 1.2.1 Global Oncology/Cancer Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Antimetabolite
- 1.2.3 Alkaloid drugs
- 1.2.4 Hormone
- 1.2.5 Targeted drug
- 1.2.6 Platinum-based drugs
- 1.2.7 Other
- 1.3 Oncology/Cancer Drugs Segment by Applications
- 1.3.1 Global Oncology/Cancer Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Blood Cancer
- 1.3.3 Breast Cancer
- 1.3.4 Gastrointestinal Cancer
- 1.3.5 Prostate Cancer
- 1.3.6 Respiratory/Lung Cancer
- 1.3.7 Other
- 1.4 Global Oncology/Cancer Drugs Overall Market
- 1.4.1 Global Oncology/Cancer Drugs Revenue (2014-2025)
- 1.4.2 Global Oncology/Cancer Drugs Production (2014-2025)
- 1.4.3 North America Oncology/Cancer Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Oncology/Cancer Drugs Status and Prospect (2014-2025)
- 1.4.5 China Oncology/Cancer Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Oncology/Cancer Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Oncology/Cancer Drugs Status and Prospect (2014-2025)
- 1.4.8 India Oncology/Cancer Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Oncology/Cancer Drugs
- 2.3 Manufacturing Process Analysis of Oncology/Cancer Drugs
- 2.4 Industry Chain Structure of Oncology/Cancer Drugs
3 Development and Manufacturing Plants Analysis of Oncology/Cancer Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Oncology/Cancer Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Oncology/Cancer Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Oncology/Cancer Drugs Production and Capacity Analysis
- 4.2 Oncology/Cancer Drugs Revenue Analysis
- 4.3 Oncology/Cancer Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Oncology/Cancer Drugs Regional Market Analysis
- 5.1 Oncology/Cancer Drugs Production by Regions
- 5.1.1 Global Oncology/Cancer Drugs Production by Regions
- 5.1.2 Global Oncology/Cancer Drugs Revenue by Regions
- 5.2 Oncology/Cancer Drugs Consumption by Regions
- 5.3 North America Oncology/Cancer Drugs Market Analysis
- 5.3.1 North America Oncology/Cancer Drugs Production
- 5.3.2 North America Oncology/Cancer Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Oncology/Cancer Drugs Import and Export
- 5.4 Europe Oncology/Cancer Drugs Market Analysis
- 5.4.1 Europe Oncology/Cancer Drugs Production
- 5.4.2 Europe Oncology/Cancer Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Oncology/Cancer Drugs Import and Export
- 5.5 China Oncology/Cancer Drugs Market Analysis
- 5.5.1 China Oncology/Cancer Drugs Production
- 5.5.2 China Oncology/Cancer Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Oncology/Cancer Drugs Import and Export
- 5.6 Japan Oncology/Cancer Drugs Market Analysis
- 5.6.1 Japan Oncology/Cancer Drugs Production
- 5.6.2 Japan Oncology/Cancer Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Oncology/Cancer Drugs Import and Export
- 5.7 Southeast Asia Oncology/Cancer Drugs Market Analysis
- 5.7.1 Southeast Asia Oncology/Cancer Drugs Production
- 5.7.2 Southeast Asia Oncology/Cancer Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Oncology/Cancer Drugs Import and Export
- 5.8 India Oncology/Cancer Drugs Market Analysis
- 5.8.1 India Oncology/Cancer Drugs Production
- 5.8.2 India Oncology/Cancer Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Oncology/Cancer Drugs Import and Export
6 Oncology/Cancer Drugs Segment Market Analysis (by Type)
- 6.1 Global Oncology/Cancer Drugs Production by Type
- 6.2 Global Oncology/Cancer Drugs Revenue by Type
- 6.3 Oncology/Cancer Drugs Price by Type
7 Oncology/Cancer Drugs Segment Market Analysis (by Application)
- 7.1 Global Oncology/Cancer Drugs Consumption by Application
- 7.2 Global Oncology/Cancer Drugs Consumption Market Share by Application (2014-2019)
8 Oncology/Cancer Drugs Major Manufacturers Analysis
- 8.1 Roche
- 8.1.1 Roche Oncology/Cancer Drugs Production Sites and Area Served
- 8.1.2 Roche Product Introduction, Application and Specification
- 8.1.3 Roche Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 HENGRUI
- 8.2.1 HENGRUI Oncology/Cancer Drugs Production Sites and Area Served
- 8.2.2 HENGRUI Product Introduction, Application and Specification
- 8.2.3 HENGRUI Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Oncology/Cancer Drugs Production Sites and Area Served
- 8.3.2 AstraZeneca Product Introduction, Application and Specification
- 8.3.3 AstraZeneca Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 QILU
- 8.4.1 QILU Oncology/Cancer Drugs Production Sites and Area Served
- 8.4.2 QILU Product Introduction, Application and Specification
- 8.4.3 QILU Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Sanofi
- 8.5.1 Sanofi Oncology/Cancer Drugs Production Sites and Area Served
- 8.5.2 Sanofi Product Introduction, Application and Specification
- 8.5.3 Sanofi Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 HANSOH
- 8.6.1 HANSOH Oncology/Cancer Drugs Production Sites and Area Served
- 8.6.2 HANSOH Product Introduction, Application and Specification
- 8.6.3 HANSOH Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 LUYE
- 8.7.1 LUYE Oncology/Cancer Drugs Production Sites and Area Served
- 8.7.2 LUYE Product Introduction, Application and Specification
- 8.7.3 LUYE Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Novartis
- 8.8.1 Novartis Oncology/Cancer Drugs Production Sites and Area Served
- 8.8.2 Novartis Product Introduction, Application and Specification
- 8.8.3 Novartis Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 GuiZhou YiBai
- 8.9.1 GuiZhou YiBai Oncology/Cancer Drugs Production Sites and Area Served
- 8.9.2 GuiZhou YiBai Product Introduction, Application and Specification
- 8.9.3 GuiZhou YiBai Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Lunan
- 8.10.1 Lunan Oncology/Cancer Drugs Production Sites and Area Served
- 8.10.2 Lunan Product Introduction, Application and Specification
- 8.10.3 Lunan Oncology/Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Eli Lilly and Company
9 Development Trend of Analysis of Oncology/Cancer Drugs Market
- 9.1 Global Oncology/Cancer Drugs Market Trend Analysis
- 9.1.1 Global Oncology/Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Oncology/Cancer Drugs Regional Market Trend
- 9.2.1 North America Oncology/Cancer Drugs Forecast 2019-2025
- 9.2.2 Europe Oncology/Cancer Drugs Forecast 2019-2025
- 9.2.3 China Oncology/Cancer Drugs Forecast 2019-2025
- 9.2.4 Japan Oncology/Cancer Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Oncology/Cancer Drugs Forecast 2019-2025
- 9.2.6 India Oncology/Cancer Drugs Forecast 2019-2025
- 9.3 Oncology/Cancer Drugs Market Trend (Product Type)
- 9.4 Oncology/Cancer Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Oncology/Cancer Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Oncology/Cancer Drugs. Industry analysis & Market Report on Oncology/Cancer Drugs is a syndicated market report, published as Global Oncology/Cancer Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Oncology/Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
